SPDR S&P Biotech ETF (NYSEARCA:XBI) Holdings Reduced by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 12.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,768 shares of the exchange traded fund’s stock after selling 1,061 shares during the period. Stratos Wealth Partners LTD.’s holdings in SPDR S&P Biotech ETF were worth $700,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in XBI. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF during the third quarter worth approximately $141,284,000. Assetmark Inc. boosted its holdings in SPDR S&P Biotech ETF by 72,653.0% during the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after buying an additional 588,489 shares in the last quarter. Sivik Global Healthcare LLC bought a new stake in SPDR S&P Biotech ETF during the third quarter worth approximately $29,640,000. Finally, Mirae Asset Securities USA Inc. boosted its holdings in SPDR S&P Biotech ETF by 50.0% during the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after buying an additional 300,000 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $90.34 on Tuesday. The stock has a market capitalization of $6.89 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The company has a 50 day moving average price of $92.40 and a 200 day moving average price of $96.38.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.